将 B 细胞与浆细胞靶向从肿瘤学转化至自身免疫:模式、定量桥接与开发路线图 Translating B-Cell and Plasma-Cell Targeting from Oncology to Autoimmunity: Modalities, Quantitative Bridging, and a Development Roadmap. PubMed 2026/06/05 发表Clin Pharmacol TherQ1 · IF 4.9(JCR 2025) 靶点:CD19靶点:CD20靶点:CD38技术:双特异性抗体淋巴瘤骨髓瘤
多发性骨髓瘤与拟态:CAR-T 细胞治疗和抗 CD38 单克隆抗体治疗后患者的胃肠道组织学表现 Multiple Myeloma and Mimicry: Gastrointestinal Tract Histologic Findings in Patients Following Chimeric Antigen Receptor T-cell Therapy and Anti-CD38 PubMed 2026/03/19 发表Mod PatholQ1 · IF 6.6(JCR 2025) 靶点:CD19靶点:CD38靶点:BCMA技术:CAR-T弥漫大B细胞淋巴瘤多发性骨髓瘤淋巴瘤
多发性骨髓瘤中的 CAR-T 细胞治疗:B 细胞成熟抗原(BCMA)及更多 CAR-T-Cell Therapy in Multiple Myeloma: B-Cell Maturation Antigen (BCMA) and Beyond. PubMed 2023/11/16 发表Vaccines (Basel)Q2 · IF 3.5(JCR 2025) 靶点:CD19靶点:CD38靶点:BCMA技术:CAR-T多发性骨髓瘤地区:美国地区:亚太其他